- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.07. | Universal Ibogaine Inc: Universal Ibogaine 4,040,067 shares for debt | 5 | Stockwatch | ||
| 18.06. | Universal Ibogaine Inc.: Universal Ibogaine to Issue Common Shares Pursuant to Debt Settlement | 8 | TheNewswire | ||
| 18.06. | Universal Ibogaine Inc: Universal Ibogaine to issue 4.04M shares to settle debt | 4 | Stockwatch | ||
| 11.06. | Universal Ibogaine Inc: Universal Ibogaine 13.5-million-share private placement | 4 | Stockwatch | ||
| 07.06. | Universal Ibogaine Inc.: Universal Ibogaine announces closing of private placement financing | 5 | TheNewswire | ||
| 07.06. | Universal Ibogaine Inc: Universal Ibogaine closes $270,000 private placement | 3 | Stockwatch | ||
| 29.04. | Universal Ibogaine Inc: Universal Ibogaine hires Changemark to help with CTA | 2 | Stockwatch | ||
| 29.04. | Universal Ibogaine Inc.: Universal Ibogaine provides update on planned Clinical Trial Application process | 2 | TheNewswire | ||
| 22.04. | Universal Ibogaine Inc: Universal Ibogaine arranges $350,000 private placement | 3 | Stockwatch | ||
| 22.04. | Universal Ibogaine Inc.: Universal Ibogaine Announces Private Placement Financing and the Results of the Annual Meeting of Shareholders | 2 | TheNewswire | ||
| 18.04. | Universal Ibogaine Inc: Universal Ibogaine 57,557,600-share private placement | 3 | Stockwatch | ||
| 12.04. | Universal Ibogaine Inc: Universal Ibogaine arranges $600,000 private placement | 3 | Stockwatch | ||
| 12.04. | Universal Ibogaine Inc.: Universal Ibogaine announces new private placement financing | 1 | TheNewswire | ||
| 10.04. | Universal Ibogaine Inc: Universal Ibogaine closes $575,576 private placement | 3 | Stockwatch | ||
| 09.04. | Universal Ibogaine Inc: Universal Ibogaine chief clinics officer Rabb departs | 2 | Stockwatch | ||
| 22.02. | Universal Ibogaine Inc: Universal Ibogaine arranges $800,000 private placement | 13 | Stockwatch | ||
| 13.02. | Universal Ibogaine Inc: Universal Ibogaine 41,719,250-share private placement | 5 | Stockwatch | ||
| 07.02. | Universal Ibogaine Inc: Universal Ibogaine closes $417,192 private placement | 1 | Stockwatch | ||
| 02.02. | Universal Ibogaine Inc: Universal Ibogaine files fiscal 2023 financials | 4 | Stockwatch |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SANOFI | 96,39 | +0,19 % | Sanofi SA-Aktie: Kurs klettert leicht (93,32 €) | An der Börse liegt die Sanofi SA-Aktie derzeit im Plus. Der jüngste Kurs betrug 93,32 Euro. Am Aktienmarkt hat sich heute die Sanofi SA-Aktie zwischenzeitlich um 0,45 Prozent verteuert. Der Kurs des... ► Artikel lesen | |
| CANOPY GROWTH | 6,750 | +0,45 % | Vor den Zahlen: Bahnt sich bei Canopy Growth, Aurora Cannabis & Co. die Trendwende an? | © Foto: adobe.stock.comDie US-Wahlen werfen ihre Schatten voraus. Auch im Cannabis-Sektor verfolgt man die aktuellen Entwicklungen mit Argusaugen. Zuletzt ließ eine Meldung die Kurse von Canopy Growth... ► Artikel lesen | |
| ASTRAZENECA | 144,35 | +1,09 % | JPMORGAN stuft ASTRAZENECA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca auf "Overweight" mit einem Kursziel von 13000 Pence belassen. Die am Donnerstag anstehenden Quartalszahlen des Pharmakonzerns dürften... ► Artikel lesen | |
| INNOCAN PHARMA | 0,171 | +1,79 % | InnoCan Pharma: Countdown für die FDA-Zulassung! | ||
| IONIS PHARMACEUTICALS | 47,230 | -0,32 % | Ionis Pharmaceuticals, Inc.: Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome | ION582 showed robust and consistent benefit in communication, cognition and motor function in a broad patient population evaluated with a comprehensive set of assessment tools that collect input from... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,328 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly's Yolks Breakfast Announces the Signing of its First Franchisee in Quebec | Toronto, Ontario--(Newsfile Corp. - July 26, 2024) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging food brands, is pleased... ► Artikel lesen | |
| CSPC PHARMA | 0,710 | +1,92 % | CSPC PHARMA (01093): CONTINUING CONNECTED TRANSACTIONS - PURSUANT TO RULE 14A.60(1) OF THE LISTING RULES | ||
| ALTIMMUNE | 6,215 | +0,05 % | Altimmune, Inc: Altimmune Announces Publication of Clinical Study of Pemvidutide in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Journal of Hepatology | ||
| AVADEL PHARMACEUTICALS | 15,200 | -1,94 % | Avadel Pharmaceuticals plc: Avadel Pharmaceuticals to Join Russell 3000 Index | DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 16,100 | -0,59 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE in Canada | CORAL GABLES, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,026 | +2,00 % | Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results | Q3 Fiscal 2024 Highlights
Revenue of $4.3 million, a 1.9% decline over Q2 2024
Gross profit of $1.0 million, a 9.8% decline over Q2 2024
Cash position of $3.7 million as of May 31, 2024
Transitioned... ► Artikel lesen | |
| ROCKET LAB USA | 5,040 | +1,41 % | Mynaric AG: Mynaric Selected by Rocket Lab for Space Development Agency's Tranche 2 Transport Layer - Beta Program | Laser Communications Manufacturer Expands Customer RosterLOS ANGELES, CA / ACCESSWIRE / May 7, 2024 / Mynaric (NASDAQ:MYNA)(FRA:M0YN), a leading provider of industrialized, cost-effective and scalable... ► Artikel lesen | |
| ONO PHARMACEUTICAL | 13,300 | -3,62 % | Ono Pharmaceutical co., ltd.: ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals | OSAKA, Japan, April 30, 2024 /PRNewswire/ -- ONO Pharmaceutical, Co., Ltd., (TSE: 4528, Representative Director, Chairman of the Board and Chief Executive Officer: Gyo Sagara, "ONO") and Deciphera... ► Artikel lesen | |
| ELANCO ANIMAL HEALTH | 11,980 | +0,88 % | Elanco (ELAN) Stock Declines After Sale of Aqua Business | ||
| QUALIGEN THERAPEUTICS | 0,226 | +2,73 % | Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination | CARLSBAD, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. ("Qualigen" or "the Company," Nasdaq: QLGN), announced today that on May 23, 2024, it received written notice (the "Delist... ► Artikel lesen |
UNIVERSAL IBOGAINE INC gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 0,001 Euro und damit -90,00 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UNIVERSAL IBOGAINE INC finden Sie auf Wallstreet Online.
